Shamburg News · 8-K filed Nov 18, 2026, 4:57 PM EST

Insight Molecular Diagnostics Launches Underwritten Public Offering Expected to Raise About $15.0 Million

IMDX · Insight Molecular Diagnostics Inc.

  • Financing
  • Material agreement
  • Other event
  • Materiality: high

On November 17, 2026, Insight Molecular Diagnostics Inc. entered into an underwriting agreement with Lake Street Capital Markets, LLC for an underwritten public offering of 8,296,429 common shares and pre-funded warrants for up to 275,000 shares at $1.75 per share. Aggregate gross proceeds are expected to be approximately $15.0 million, and the Underwriter received a 30-day option to buy up to an additional 1,285,714 shares. The offering is expected to close on or about November 18, 2026, and the Company agreed to a 90-day lock-up on further share issuances, subject to exceptions.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 8.01, 9.01, accession 0001493152-26-053091.

Written from the filing by Shamburg Markets. Figures are as reported by the company.